disease specific epitope-targeting monoclonal antibodies (Biogen)

N/A

Report date: 2025/03/19 09:02:45

Base Information

Drug Namedisease specific epitope-targeting monoclonal antibodies (Biogen)
Drug Alias Nameanti-SOD-1 program (Biogen Idec)anti-SOD-1 program (Biogen)disease specific epitope-targeting monoclonal antibodies (Biogen Idec)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionSuperoxide dismutase modulators
TargetsSuperoxide dismutase
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesProMIS Neurosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesBiogen Inc
Inactive CompaniesProMIS Neurosciences Inc
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A